in the top right of your browser window and click the 
at the top of the menu
in the top right of your browser window and click “Add Bookmark
You are about to leave the Get Smart about AFib website and go to an external website.
Atrial Fibrillation is the most common form of cardiac arrhythmia and is becoming one of the most important public health challenges, affecting over 11 million people across Europe1
Atrial Fibrillation can be a debilitating condition for patients, significantly impacting their quality of life. But beware that up to 30% of people with Atrial Fibrillation are asymptomatic and uncovering these patients remains a challenge. Early detection could allow for earlier management and avoid later complications.2
The risk of Atrial Fibrillation increases with age, doubling each decade after 553 What other risk factors are important to consider?
Up to 30% of all strokes occur in people with Atrial Fibrillation.4,5 What is the best way to assess their risk and what interventions are recommended to prevent the occurrence of stroke?
Atrial Fibrillation – New Millennium Epidemic
Product Description text
AF not only reduces the quality of life for patients but costs healthcare systems up to €3.286 million annually across Europe.
Watch this video to gain insight into the new millennial epidemic called Atrial Fibrillation or click through to find out more on the burden of the disease.
ESC Guidelines
ESC Guidelines for the management of AF at a glance: summary of everything you need to know about the new millennium epidemic.
References
1. Global Burden of Disease Collaborative Network (2016) Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2017. Accessed 2018-04-20. Available from http://ghdx.healthdata.org/gbd-results-tool. 2. Mairesse G et al. Europace 2017: (19) 1589-1623 Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). 3. ahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO et al. (2007) Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 115 (24): 3050-3056. 4. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D et al. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (38): 2893-2962. 5. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6 213-220.
113954-190718 EMEA; 115115-190526 EMEA; 115114-190526 EMEA; 095103-180713 EMEA; 101640-181029 EMEA; 094573-180706 EMEA; 115113-190526 EMEA; 115110-190524 EMEA; 116706-190614 EMEA